secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-06-08T20:41:08+00:00
Accession:  0001193125-26-261910
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health stockholders approve all five proposals, including share issuances up to >19.99% to C/M Capital
--------------------------------------------------------------------------------

- John Micek III elected Class II director with 3,967,085 for, 240,944 withheld.
- Ratification of RBSM LLP as auditor approved: 6,898,326 for.
- Proposal 3 (ELOC Agreement with C/M Capital) approved: 3,891,273 for, 291,441 against.
- Proposal 4 (Preferred Stock Purchase Agreement with C/M Capital, including Series P Preferred) approved: 3,846,847 for.
- Proposal 5 (adjournment authority) approved: 3,928,027 for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526261910/0001193125-26-261910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526261910/d85703d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-261910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer